Original Query: ALL
Previous Study | Return to List | Next Study

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00770536
Recruitment Status : Completed
First Posted : October 10, 2008
Last Update Posted : September 29, 2015
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2012
  Study Completion Date : June 2015